Financhill
Back

Sonoma Pharmaceuticals Stock Predictions

Sonoma Pharmaceuticals Stock Forecast

  • Is Sonoma Pharmaceuticals Stock Undervalued?
    The current Sonoma Pharmaceuticals [SNOA] share price is $2.85. The Score for SNOA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • SNOA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Sonoma Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Sonoma Pharmaceuticals Stock Rating

Data Unavailable

Sonoma Pharmaceuticals Stock Price History

Is SNOA stock going to rise?

  • The current trend is relatively stagnant and SNOA is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
sonomapharma.com

52-Week Data

52-Week High:
9.37
52-Week Low:
2.52

Prediction Charts

Market Cap:
3.82M
Price in USD:
2.85
Volume:
526.77K
Beta:
1.52

Technical Analysis

SMA50:
3.04
SMA100:
4.23
SMA200:
3.82
52-Wk Change:
-18.48%

Stock Predictions

  • Is Sonoma Pharmaceuticals stock public?
    Yes, Sonoma Pharmaceuticals is a publicly traded company.
  • What is the Sonoma Pharmaceuticals stock quote today?
    The Sonoma Pharmaceuticals stock price is 2.85 USD today.
  • How to buy Sonoma Pharmaceuticals stock online?
    You can buy Sonoma Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 2.77 2.84 2.89 2.74
Nov-6 3.04 2.86 3.04 2.86
Nov-7 2.95 2.92 3.04 2.79
Nov-8 2.93 2.80 3.00 2.76
Nov-11 3.18 3.02 3.50 2.93
Nov-12 2.85 2.69 2.99 2.60
Nov-13 2.70 2.61 2.76 2.60
Nov-14 2.84 2.58 2.84 2.56
Nov-15 2.60 2.56 2.64 2.56
Nov-18 2.64 2.58 2.64 2.55
Nov-19 3.29 3.16 3.60 2.78
Nov-20 3.15 2.84 3.17 2.83
Nov-21 2.86 2.91 3.07 2.70
Nov-22 2.89 2.85 3.14 2.84

Sonoma Pharmaceuticals Earnings

Data Unavailable

Sonoma Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.60 per share.

* Sonoma Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.